OLV Ziekenhuis Aalst — Aalst, Oost-Vlaanderen

Public research footprint of OLV Ziekenhuis Aalst, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Peripheral Arterial Disease · Acute Myocardial Infarction · Recurrent or Metastatic, Platinum-refractory Cervical Cancer · Coronary Artery Disease

Recently updated registry entries

NCT05197049 — A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely… (Active Not Recruiting)
NCT03748641 — A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus… (Active Not Recruiting)
NCT03487445 — A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at OLV Ziekenhuis Aalst?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.